FUNDING:
This study was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)-sponsored Pelvic Floor Disorders Network (PFDN) (U10 HD054214 University of California San Diego, California; U10 HD041267 Duke University, North Carolina; U10 HD041261 University of Alabama at Birmingham, Alabama; U10 HD069013 Brown Women and Infants Hospital, Rhode Island; U10 HD069025 University of New Mexico, New Mexico; U10 HD069010 University of Pennsylvania, Pennsylvania; U10 HD069006 University of Pittsburgh, Pennsylvania; U10 HD054215 Cleveland Clinic, Ohio; U01 HD069031 RTI International, North Carolina) and the National Institutes of Health Office of Research on Women’s Health (NIH-ORWH). The NICHD project scientist (DM) for the PFDN at the time of this study had a role in the development of the protocol and management of the study; preparation, review, and approval of the manuscript. The funding of the study was managed by other NIH employees.
Partial support for this study was supplied by Boston Scientific Corporation through an unrestricted grant to the Pelvic Floor Disorders Network Data Coordinating Center, RTI International. Boston Scientific had no role in study design; collection, management, analysis, and interpretation of data; writing of the manuscript; or the decision to submit the manuscript for publication.
Research training support for STB was provided by the National Academies of Sciences, Engineering, and Medicine ’s Ford Foundation Predoctoral Fellowship Program. The Ford Foundation had a role in providing research training support. The Ford Foundation had no role in study design; collection, management, analysis, and interpretation of data; writing of the manuscript; or the decision to submit the manuscript for publication.
The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Ford Foundation.